Sinovac Biotech, Ltd (SVA) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for SVA. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 29 institutions reported holding SVA, with 10.5 million shares worth $224.9 million in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Vivo Capital | 5,903,000 | $38M | UNCHANGED |
| Orbimed Advisors | 2,718,735 | $184M | UNCHANGED |
| Renaissance Technologies | 1,312,520 | UNCHANGED | |
| Neumann Advisory Hong Kong | 315,586 | $2M | UNCHANGED |
| CalPERS | 68,732 | UNCHANGED |
Full institutional holdings, insider history, and congressional trades for Sinovac Biotech, Ltd on SentiSense.